About “Mauricio Reginato”
- Postdoctoral Fellow, Harvard Medical School
- PhD – Pharmacology, University of Pennsylvania
- BS – Biology, Penn State University
AWARDS & HONORS
- Drexel University College of Medicine, Julian Marsh Faculty Scholar Award (2021)
- Drexel University College of Medicine, Elias Abrutyn Mentoring Award (2018)
- Drexel University College of Medicine, Faculty Mentoring Award, MS Research Intensive Programs, Graduate Student Association (2016)
- Drexel University College of Medicine, Young Investigator Award (2010)
Their lab is interested in understanding altered signaling pathways that lead to cancer initiation and progression and metastasis. Identifying and understanding these pathways will lead to development of novel therapies. Their lab is interested in understanding how signaling pathways regulate metabolic reprograming in cancer cells.
They are particularly interested in breast cancer. Every year approximately 200,000 new cases of breast cancer are diagnosed, and 40,000 women are expected to die from this disease in the U.S. alone. Their labs long-term goal is to identify novel therapeutic targets for treatment of breast cancer. They are trying to understand alterations in cellular signaling pathways between normal and cancer cells and exploit these differences for possible therapeutic gain.